August 2016 Issue Table Of Contents

From The Editor

• Brexit Shmexit — Let’s Keep Calm And Carry On

Feature Articles

• One-On-One With Celgene’s CEO
• How Pharma Can Create Environments That Go Beyond Being Just Cutting Edge

The Enterprisers

• Life Science Leadership In Action: RespireRx

Capitol Perspectives

• If Government Fails, More Government!

Companies To Watch

• Enteris BioPharma

CEO Corner

• The Constant Search For More Efficient Paths To Approval

Inside The Industry

• Why Proactive Risk Mgt. Is The Only Solution To The New Regulatory Reality
• Identify New Revenue Streams Via Strategic Consulting Partners
• How BMS Is Leveraging The Patient Voice To Improve Clinical Trials
• Taking The Guesswork Out Of Drug Development

Leadership Lessons

• Executive Well-Being – Body, Mind, And Purpose

Ask The Board

• What Simple Solutions Can Biopharma Executives Implement To Positively Impact Public Perception?
• What Mechanisms Can Be Used To Encourage U.S. Companies To Bring Back Their Overseas “Stranded Capital”?
• Knowing What You Know Now, What Would You Do Differently In Founding A Biopharma Company?